Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-08-16 Sale |
2021-08-17 4:46 pm |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CHIEF EXECUTIVE OFFICER |
16,666 | $60.46 | $1,007,626 | 544,641 (Direct) |
View |
2021-08-13 Sale |
2021-08-17 4:46 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
9,000 | $61.13 | $550,190 | 63,796 (Direct) |
View |
2021-08-09 Sale |
2021-08-10 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
12,000 | $64.34 | $772,100 | 127,495 (Direct) |
View |
2021-08-02 Sale |
2021-08-03 4:45 pm |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT AND CSO |
15,000 | $55.76 | $836,400 | 213,925 (Direct) |
View |
2021-08-03 Sale |
2021-08-03 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
2,000 | $54.93 | $109,860 | 74,796 (Direct) |
View |
2021-07-27 Sale |
2021-07-28 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
3,000 | $52.58 | $157,740 | 76,796 (Direct) |
View |
2021-07-20 Sale |
2021-07-21 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
3,000 | $50.9 | $152,700 | 79,796 (Direct) |
View |
2021-07-20 Sale |
2021-07-21 4:45 pm |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
13,242 | $50.34 | $666,602 | 104,718 (Direct) |
View |
2021-07-08 Sale |
2021-07-09 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
13,435 | $56.05 | $753,032 | 147,495 (Direct) |
View |
2021-07-02 Sale |
2021-07-02 4:45 pm |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT AND CSO |
15,000 | $57.81 | $867,150 | 233,397 (Direct) |
View |
2021-06-28 Sale |
2021-06-30 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
3,421 | $63 | $215,523 | 82,796 (Direct) |
View |
2021-06-24 Sale |
2021-06-25 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
4,000 | $60 | $240,000 | 86,217 (Direct) |
View |
2021-06-17 Sale |
2021-06-21 4:15 pm |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
13,242 | $53.44 | $707,652 | 117,960 (Direct) |
View |
2021-06-07 Sale |
2021-06-08 4:46 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
14,500 | $52.62 | $762,990 | 168,351 (Direct) |
View |
2021-06-04 Sale |
2021-06-08 4:45 pm |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT |
15,000 | $50.9 | $763,500 | 248,397 (Direct) |
View |
2021-05-17 Sale |
2021-05-19 4:45 pm |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT |
15,000 | $42.95 | $644,250 | 9,079 (Direct) |
View |
2021-05-17 Sale |
2021-05-19 4:45 pm |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
13,242 | $42.72 | $565,698 | 144,444 (Direct) |
View |
2021-05-18 Sale |
2021-05-19 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
14,500 | $45.85 | $664,825 | 182,851 (Direct) |
View |
2021-03-24 Sale |
2021-03-26 4:45 pm |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CHIEF EXECUTIVE OFFICER |
100,000 | $46.98 | $4,698,000 | 561,307 (Direct) |
View |
2021-01-29 Sale |
2021-01-29 4:46 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
5,032 | $47.25 | $237,762 | 197,351 (Direct) |
View |
2021-01-13 Sale |
2021-01-15 4:45 pm |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
5,000 | $38.89 | $194,450 | 187,930 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-08-09 Exercise |
2021-08-10 4:45 pm |
2020-06-30 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
10,000 | $7.51 | 127,495 (Direct) |
View |
2021-08-02 Exercise |
2021-08-03 4:45 pm |
2020-03-31 2025-03-11 |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT AND CSO |
15,000 | $0 | 213,925 (Direct) |
View |
2021-08-02 Exercise |
2021-08-03 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT AND CSO |
15,000 | $7.51 | 213,925 (Direct) |
View |
2021-07-20 Exercise |
2021-07-21 4:45 pm |
2020-06-30 2025-03-11 |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
13,242 | $0 | 104,718 (Direct) |
View |
2021-07-20 Exercise |
2021-07-21 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
13,242 | $7.51 | 104,718 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 4:15 pm |
2020-07-27 2022-07-27 |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT |
71,667 | $0 | 228,925 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 4:15 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT |
67,195 | $3.15 | 228,925 (Direct) |
View |
2021-07-08 Exercise |
2021-07-09 4:45 pm |
2017-12-31 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
13,435 | $0 | 147,495 (Direct) |
View |
2021-07-08 Exercise |
2021-07-09 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
13,435 | $2.46 | 147,495 (Direct) |
View |
2021-07-02 Exercise |
2021-07-02 4:45 pm |
2018-07-27 2022-07-27 |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT AND CSO |
15,000 | $0 | 233,397 (Direct) |
View |
2021-07-02 Exercise |
2021-07-02 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT AND CSO |
15,000 | $3.15 | 233,397 (Direct) |
View |
2021-06-30 Option Award |
2021-06-30 4:49 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
407 | $0 | 17,931 (Direct) |
View |
2021-06-30 Option Award |
2021-06-30 4:49 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
407 | $0 | 32,890 (Direct) |
View |
2021-06-30 Option Award |
2021-06-30 4:48 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
407 | $0 | 22,335 (Direct) |
View |
2021-06-30 Option Award |
2021-06-30 4:48 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
407 | $0 | 32,660 (Direct) |
View |
2021-06-30 Option Award |
2021-06-30 4:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
407 | $0 | 64,828 (Direct) |
View |
2021-06-17 Exercise |
2021-06-21 4:15 pm |
2020-03-31 2025-03-11 |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
13,242 | $0 | 117,960 (Direct) |
View |
2021-06-17 Exercise |
2021-06-21 4:15 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
13,242 | $7.51 | 117,960 (Direct) |
View |
2021-06-07 Exercise |
2021-06-08 4:46 pm |
2017-12-31 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
14,500 | $0 | 168,351 (Direct) |
View |
2021-06-07 Exercise |
2021-06-08 4:46 pm |
N/A N/A |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
14,500 | $2.46 | 168,351 (Direct) |
View |
2021-06-04 Exercise |
2021-06-08 4:45 pm |
2018-07-27 2022-07-27 |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT |
13,333 | $0 | 248,397 (Direct) |
View |
2021-06-04 Exercise |
2021-06-08 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT |
13,333 | $3.15 | 248,397 (Direct) |
View |
2021-05-17 Exercise |
2021-05-19 4:45 pm |
2020-03-31 2025-03-11 |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
13,242 | $0 | 144,444 (Direct) |
View |
2021-05-17 Exercise |
2021-05-19 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
13,242 | $7.51 | 144,444 (Direct) |
View |
2021-05-18 Exercise |
2021-05-19 4:45 pm |
2017-12-31 2022-03-31 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
14,500 | $0 | 182,851 (Direct) |
View |
2021-05-18 Exercise |
2021-05-19 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
14,500 | $2.46 | 182,851 (Direct) |
View |
Ownership |
2021-05-07 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Inman Todd Chief Technology Officer |
0 | $0 | 10,000 (Direct) |
View |
2021-03-31 Option Award |
2021-04-02 12:44 pm |
N/A N/A |
OptimizeRx Corp | OPRX | WASSON GREGORY D Director |
539 | $0 | 17,524 (Direct) |
View |
2021-03-31 Option Award |
2021-04-02 12:42 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Vos Ellen O'Connor Director |
539 | $0 | 32,483 (Direct) |
View |
2021-03-31 Option Award |
2021-04-02 12:40 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Spangler Patrick D Director |
539 | $0 | 21,928 (Direct) |
View |
2021-03-31 Option Award |
2021-04-02 12:38 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
539 | $0 | 32,253 (Direct) |
View |
2021-03-31 Option Award |
2021-04-02 12:33 pm |
N/A N/A |
OptimizeRx Corp | OPRX | HALAS GUS D Director |
539 | $0 | 64,421 (Direct) |
View |
2021-03-25 Exercise |
2021-03-26 4:45 pm |
2019-02-22 2021-05-21 |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CHIEF EXECUTIVE OFFICER |
394,739 | $0 | 561,307 (Direct) |
View |
2021-03-25 Exercise |
2021-03-26 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CHIEF EXECUTIVE OFFICER |
394,739 | $3.21 | 561,307 (Direct) |
View |
2021-03-25 Tax Withholding |
2021-03-26 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CHIEF EXECUTIVE OFFICER |
26,710 | $47.44 | 561,307 (Direct) |
View |
2021-02-11 Option Award |
2021-02-12 4:46 pm |
2022-02-11 2026-02-11 |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2021-02-11 4:50 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Odence-Ford Marion General Counsel and CCO |
0 | $0 | 0 (Direct) |
View |
2021-01-29 Exercise |
2021-01-29 4:46 pm |
2020-03-31 2025-03-11 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
4,315 | $7.51 | 197,351 (Direct) |
View |
2020-09-30 Option Award |
2021-01-20 8:23 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Lang James Paul Director |
1,985 | $0 | 31,714 (Direct) |
View |
2021-01-13 Exercise |
2021-01-15 4:45 pm |
2020-03-31 2025-03-11 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
5,000 | $7.51 | 187,930 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 7:05 pm |
2021-01-07 2024-01-07 |
OptimizeRx Corp | OPRX | Silvestro Stephen L CHIEF COMMERCIAL OFFICER |
38,511 | $0 | 144,444 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 7:04 pm |
2021-01-07 2024-01-07 |
OptimizeRx Corp | OPRX | Paramore Miriam J PRESIDENT |
24,093 | $0 | 254,318 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 7:04 pm |
2021-01-07 2024-01-07 |
OptimizeRx Corp | OPRX | FEBBO WILLIAM J CHIEF EXECUTIVE OFFICER |
28,883 | $0 | 28,883 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 7:04 pm |
2021-01-07 2024-01-07 |
OptimizeRx Corp | OPRX | BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
14,456 | $0 | 116,449 (Direct) |
View |